Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion
By Michael Erman and Manas MishraAug 26 (Reuters) - Amgen Inc will buy Celgene Corp's psoriasis drug Otezla for $13.4 billion in cash, clearing the way for...
By Michael Erman and Manas MishraAug 26 (Reuters) - Amgen Inc will buy Celgene Corp's psoriasis drug Otezla for $13.4 billion in cash, clearing the way for...